Biotechnology Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results Read more
Commodities US court gets 12 preliminary bids in Citgo share auction Reuters via biedexmarkets.com Read more
Biotechnology Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics’ AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002 – Elicio Therapeutics (NASDAQ:ELTX) Read more